Predictive clinical analytic solutions provider Elsevier / MEDai, US, has announced the appointment of two key clinicians to its leadership team. Dr. Peter Edelstein has been appointed Chief Medical Officer, and Dr. Gerald Osband has been appointed Director, Product Strategy.
Dr. Edelstein brings a wealth of knowledge to the organisation, including 17 years in the clinical arena and healthcare industry. With board certifications from both the American College of Surgeons and the American Society of Colon and Rectal Surgery, Dr. Edelstein was in private practice before serving on the Surgical Faculty at Stanford University, focusing on gastrointestinal, oncologic, and trauma surgery. He then spent more than a decade as an executive in the Silicon Valley medical device industry. Before joining Elsevier/MEDai, Dr. Edelstein most recently served as a physician executive within the Adventist Health System.
Dr. Osband is a seasoned clinician and physician executive whose senior level positions include Chief Medical Officer and Chief Operations Officer for nationally recognized healthcare management and technology organizations. He has provided independent consulting services for several major TPAs and a data management and guidelines organisation. His clinical experience is the result of 18 years of family medicine practice, including positions teaching family medicine residents and nurse practitioners. His extensive experience in providing clinical and administrative guidance to software application development for care management, core administration, value-based incentives and value-based reimbursement products for commercial, Medicare and Medicaid programs will be invaluable to MEDai clients.
